Would you recommend covering the dissected axilla in your radiation field in patients with cN2/N3 disease who had complete response to neoadjuvant chemo and an ALND?   

What if ALND reveals no residual disease?



Answer from: Radiation Oncologist at Academic Institution

Answer from: Radiation Oncologist at Community Practice
Comments
Radiation Oncologist at Naval Medical Center San Diego
I am considering boosting potential residual LNs (...
Radiation Oncologist at Varian Medical Systems/Allegheny health network
No outcome data, but the practice pattern is based...
Radiation Oncologist at Cleveland Clinic
Agreed, if I see residual based on planning, I do ...
Sign in or Register to read more